mometasone furoate 0.001 MG/MG Topical Ointment

RxCUI: 151029
RxNorm name: mometasone furoate 0.001 MG/MG Topical Ointment
Display name: Mometasone (Topical)
Full name: mometasone furoate 0.001 MG/MG Topical Ointment
Term type: SCD
Status: Active
Strength: 0.1%
Dose form: Ointment
Route: Topical
Updated: 2026-10-17 23:56:11

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 042005
Active start: 042005
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
mometasone furoate	0.001 MG / 1 MG	mometasone	mometasone furoate

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Topical Ointment	316985

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
mometasone	108118

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	mometasone furoate 0.001 MG/MG Topical Ointment	1	NAMES
RxNorm Name	mometasone furoate 0.001 MG/MG Topical Ointment	1	NAMES
RxNorm Synonym	2 linked values mometasone furoate 0.1 % Topical Ointment mometasone furoate 1 MG/GM Topical Ointment	2	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	13 linked values 5eda1256-001a-4f40-b3ca-15349d532033 9fe65193-b4d8-480b-89b3-178cd1b20713 18ef90de-f74d-492f-a125-49da1875bd29 43a91066-1d85-4f67-9856-a11c1bb2b22b 45c9512b-9463-4684-bfdb-742644d77cc3 a6055a9c-e19c-48ad-a743-c0a7f7366cdd bfe3d098-a5f8-4e5d-9fa6-eac167bad3e9 c08fcb0d-7fff-4d90-aeb8-e912b930bf3d c3053a64-9044-496e-9005-12b4440d46e8 d986282f-da3c-43b6-a3f6-40886d4a1915 dae3eaea-fc17-48a2-ae30-2a68f7811bce f02dea3f-9e4f-4c5a-bea3-f428afca803b f5b30e5e-b067-e28c-b7c5-aa58f4c57f09	13	CODES
RxCUI	151029	1	CODES
MMSL_CODE	2 linked values BD199 CD199	2	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
0713-0635-15	0713-0635	Mometasone Furoate Mometasone Furoate	Cosette Pharmaceuticals, Inc.	ANDA077401
0713-0635-37	0713-0635	Mometasone Furoate Mometasone Furoate	Cosette Pharmaceuticals, Inc.	ANDA077401
13668-527-01	13668-527	Mometasone Furoate Mometasone Furoate	Torrent Pharmaceuticals Limited	ANDA207899
13668-527-04	13668-527	Mometasone Furoate Mometasone Furoate	Torrent Pharmaceuticals Limited	ANDA207899
21922-071-04	21922-071	Mometasone furoate Mometasone furoate	Encube Ethicals, Inc.	ANDA076481
21922-071-06	21922-071	Mometasone furoate Mometasone furoate	Encube Ethicals, Inc.	ANDA076481
45802-119-37	45802-119	Mometasone Furoate Mometasone Furoate	Padagis Israel Pharmaceuticals Ltd	ANDA076067
45802-119-42	45802-119	Mometasone Furoate Mometasone Furoate	Padagis Israel Pharmaceuticals Ltd	ANDA076067
50090-1633-0	50090-1633	Mometasone Furoate Mometasone Furoate	A-S Medication Solutions	ANDA076067
63629-8683-1	63629-8683	Mometasone Furoate Mometasone Furoate	Bryant Ranch Prepack	ANDA076067
63629-8684-1	63629-8684	Mometasone Furoate Mometasone Furoate	Bryant Ranch Prepack	ANDA076067
63629-9305-1	63629-9305	Mometasone Furoate Mometasone Furoate	Bryant Ranch Prepack	ANDA076067
63629-9306-1	63629-9306	Mometasone Furoate Mometasone Furoate	Bryant Ranch Prepack	ANDA076067
68788-8357-4	68788-8357	Mometasone Furoate Mometasone Furoate	Preferred Pharmaceuticals Inc.	ANDA076067
71205-413-15	71205-413	Mometasone Furoate Mometasone Furoate	Proficient Rx LP	ANDA076067
72162-1393-2	72162-1393	Mometasone Furoate Mometasone Furoate	Bryant Ranch Prepack	ANDA076067
72162-1393-4	72162-1393	Mometasone Furoate Mometasone Furoate	Bryant Ranch Prepack	ANDA076067
85766-181-15	85766-181	Mometasone Furoate Mometasone Furoate	Sportpharm LLC	ANDA076067

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
ANDA077401	0713-0635	Mometasone Furoate Mometasone Furoate	ANDA	Cosette Pharmaceuticals, Inc.
ANDA207899	13668-527	Mometasone Furoate Mometasone Furoate	ANDA	Torrent Pharmaceuticals Limited
ANDA076481	21922-071	Mometasone furoate Mometasone furoate	ANDA	Encube Ethicals, Inc.
ANDA076067	45802-119	Mometasone Furoate Mometasone Furoate	ANDA	Padagis Israel Pharmaceuticals Ltd

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 64 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00168027115	rxnav_ndcs	yes
00168027146	rxnav_ndcs	yes
00713063515	rxnav_ndcs	yes
00713063537	rxnav_ndcs	yes
00713072715	rxnav_ndcs	yes
00713072737	rxnav_ndcs	yes
00781706819	rxnav_ndcs	yes
13668052701	rxnav_ndcs	yes
13668052704	rxnav_ndcs	yes
21922007104	rxnav_ndcs	yes
21922007106	rxnav_ndcs	yes
45802011937	rxnav_ndcs	yes
45802011942	rxnav_ndcs	yes
50090102600	rxnav_ndcs	yes
50090163300	rxnav_ndcs	yes
63629868301	rxnav_ndcs	yes
63629868401	rxnav_ndcs	yes
63629930501	rxnav_ndcs	yes
63629930601	rxnav_ndcs	yes
68071132805	rxnav_ndcs	yes
68462022517	rxnav_ndcs	yes
68462022555	rxnav_ndcs	yes
68788835704	rxnav_ndcs	yes
71205041315	rxnav_ndcs	yes
72162139302	rxnav_ndcs	yes
72162139304	rxnav_ndcs	yes
85766018115	rxnav_ndcs	yes
00085037001	rxnav_historical
00085037002	rxnav_historical
00115146946	rxnav_historical
00115146952	rxnav_historical
00247208615	rxnav_historical
00247208745	rxnav_historical
00247208815	rxnav_historical
00247208945	rxnav_historical
00713063545	rxnav_historical
00781706827	rxnav_historical
25463027115	rxnav_historical
25463027146	rxnav_historical
42254017545	rxnav_historical
51672131101	rxnav_historical
51672131106	rxnav_historical
52125026501	rxnav_historical
52125026515	rxnav_historical
53002004063	rxnav_historical
54569591500	rxnav_historical
54868222500	rxnav_historical
54868622000	rxnav_historical
54868622001	rxnav_historical
61360131101	rxnav_historical
61360131106	rxnav_historical
63646010701	rxnav_historical
63646010702	rxnav_historical
63646010719	rxnav_historical
63646010727	rxnav_historical
67405030015	rxnav_historical
67405030045	rxnav_historical
67438011937	rxnav_historical
67438011942	rxnav_historical
68071446004	rxnav_historical
68258399704	rxnav_historical
70518017500	rxnav_historical
70518053100	rxnav_historical
70518324400	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 13 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mometasone Furoate	MOMETASONE FUROATE	Padagis Israel Pharmaceuticals Ltd	d986282f-da3c-43b6-a3f6-40886d4a1915	2026-08-27	Warnings, Adverse reactions	Exact identifier ndc (package): 45802-119-37 ndc (package): 45802-119-42 ndc (product): 45802-119 ndc11 (package): 45802011937 ndc11 (package): 45802011942 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	Torrent Pharmaceuticals Limited	18ef90de-f74d-492f-a125-49da1875bd29	2026-08-06	Warnings, Adverse reactions	Exact identifier ndc (package): 13668-527-04 ndc (package): 13668-527-01 ndc (product): 13668-527 ndc11 (package): 13668052704 ndc11 (package): 13668052701 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	Preferred Pharmaceuticals Inc.	bfe3d098-a5f8-4e5d-9fa6-eac167bad3e9	2026-07-17	Warnings, Adverse reactions	Exact identifier ndc (package): 68788-8357-4 ndc (product): 68788-8357 ndc11 (package): 68788835704 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	Bryant Ranch Prepack	5eda1256-001a-4f40-b3ca-15349d532033	2026-05-21	Warnings, Adverse reactions	Exact identifier ndc (package): 72162-1393-2 ndc (package): 72162-1393-4 ndc (product): 72162-1393 ndc11 (package): 72162139304 ndc11 (package): 72162139302 rxcui: 151029
Mometasone furoate	MOMETASONE FUROATE	Encube Ethicals, Inc.	dae3eaea-fc17-48a2-ae30-2a68f7811bce	2026-04-06	Warnings, Adverse reactions	Exact identifier ndc (package): 21922-071-06 ndc (package): 21922-071-04 ndc (product): 21922-071 ndc11 (package): 21922007104 ndc11 (package): 21922007106 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	Sportpharm LLC	f02dea3f-9e4f-4c5a-bea3-f428afca803b	2026-03-19	Warnings, Adverse reactions	Exact identifier ndc (package): 85766-181-15 ndc (product): 85766-181 ndc11 (package): 85766018115 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	Bryant Ranch Prepack	43a91066-1d85-4f67-9856-a11c1bb2b22b	2024-11-20	Warnings, Adverse reactions	Exact identifier ndc (package): 63629-8683-1 ndc (product): 63629-8683 ndc11 (package): 63629868301 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	Bryant Ranch Prepack	45c9512b-9463-4684-bfdb-742644d77cc3	2024-08-14	Warnings, Adverse reactions	Exact identifier ndc (package): 63629-9306-1 ndc (product): 63629-9306 ndc11 (package): 63629930601 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	Cosette Pharmaceuticals, Inc.	f5b30e5e-b067-e28c-b7c5-aa58f4c57f09	2023-11-29	Warnings, Adverse reactions	Exact identifier ndc (package): 0713-0635-37 ndc (package): 0713-0635-15 ndc (product): 0713-0635 ndc11 (package): 00713063515 ndc11 (package): 00713063537 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	Bryant Ranch Prepack	c3053a64-9044-496e-9005-12b4440d46e8	2023-10-20	Warnings, Adverse reactions	Exact identifier ndc (package): 63629-9305-1 ndc (product): 63629-9305 ndc11 (package): 63629930501 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	Bryant Ranch Prepack	a6055a9c-e19c-48ad-a743-c0a7f7366cdd	2023-07-18	Warnings, Adverse reactions	Exact identifier ndc (package): 63629-8684-1 ndc (product): 63629-8684 ndc11 (package): 63629868401 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	A-S Medication Solutions	9fe65193-b4d8-480b-89b3-178cd1b20713	2023-02-15	Warnings, Adverse reactions	Exact identifier ndc (package): 50090-1633-0 ndc (product): 50090-1633 ndc11 (package): 50090163300 rxcui: 151029
Mometasone Furoate	MOMETASONE FUROATE	Proficient Rx LP	c08fcb0d-7fff-4d90-aeb8-e912b930bf3d	2020-02-01	Warnings, Adverse reactions	Exact identifier ndc (package): 71205-413-15 ndc (product): 71205-413 ndc11 (package): 71205041315 rxcui: 151029

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 19 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
43a91066-1d85-4f67-9856-a11c1bb2b22b	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	104	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20241120
a6055a9c-e19c-48ad-a743-c0a7f7366cdd	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	103	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20230718
45c9512b-9463-4684-bfdb-742644d77cc3	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	102	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20240814
c3053a64-9044-496e-9005-12b4440d46e8	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	102	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20231020
5eda1256-001a-4f40-b3ca-15349d532033	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	101	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20260521
9fe65193-b4d8-480b-89b3-178cd1b20713	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	10	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20230215
d986282f-da3c-43b6-a3f6-40886d4a1915	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	9	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20230101
18ef90de-f74d-492f-a125-49da1875bd29	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	8	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE Ointment, 0.1% for topical use Initial U.S. Approval: 1987	20260508
f5b30e5e-b067-e28c-b7c5-aa58f4c57f09	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	8	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment 0.1%, for topical use Initial U.S. Approval: 1987	20231129
6e1d81d2-9e07-40d4-8f52-859f26c3776b	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	7	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE Ointment, 0.1% for topical use Initial U.S. Approval: 1987	20210825
209c15dd-72b2-4f00-a2f0-011219f7eaea	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	7	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE Ointment, 0.1% for topical use Initial U.S. Approval: 1987	20210223
d8cf50d4-0448-4527-a498-cddd511213f0	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	5	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20250707
bfe3d098-a5f8-4e5d-9fa6-eac167bad3e9	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	3	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20250813
8c0c49c9-aa28-4587-869e-b40368152540	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	2		20101228
dae3eaea-fc17-48a2-ae30-2a68f7811bce	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	1	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE OINTMENT, for Topical Use Initial U.S. Approval: 1987	20260406
f02dea3f-9e4f-4c5a-bea3-f428afca803b	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	1	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20260319
c08fcb0d-7fff-4d90-aeb8-e912b930bf3d	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	1	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	20200201
79957ee5-5d59-45a9-8ff8-10cc75848d2a	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	1	Mometasone Furoate Ointment 0.1% For dermatologic use only- not for ophthalmic use	20120306
db303d11-eba4-49f7-bf9c-7d944ddb43e7	mometasone furoate 0.1 % Topical Ointment [PSN] · mometasone furoate 0.001 MG/MG Topical Ointment [SCD] · mometasone furoate 0.1 % Topical Ointment [SY] · mometasone furoate 1 MG/GM Topical Ointment [SY]	4	1		20120214

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
d986282f-da3c-43b6-a3f6-40886d4a1915	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Padagis Israel Pharmaceuticals Ltd	20260827
18ef90de-f74d-492f-a125-49da1875bd29	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Torrent Pharmaceuticals Limited \| Torrent Pharma, Inc.	20260806
bfe3d098-a5f8-4e5d-9fa6-eac167bad3e9	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Preferred Pharmaceuticals Inc.	20260717
5eda1256-001a-4f40-b3ca-15349d532033	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Bryant Ranch Prepack	20260521
18ef90de-f74d-492f-a125-49da1875bd29	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE Ointment, 0.1% for topical use Initial U.S. Approval: 1987	Torrent Pharmaceuticals Limited \| Torrent Pharma, Inc.	20260508
dae3eaea-fc17-48a2-ae30-2a68f7811bce	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE OINTMENT, for Topical Use Initial U.S. Approval: 1987	Encube Ethicals, Inc. \| Encube Ethicals Private Limited	20260406
f02dea3f-9e4f-4c5a-bea3-f428afca803b	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Sportpharm LLC	20260319
bfe3d098-a5f8-4e5d-9fa6-eac167bad3e9	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Preferred Pharmaceuticals Inc.	20250813
d8cf50d4-0448-4527-a498-cddd511213f0	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Sun Pharmaceutical Industries, Inc. \| Sun Pharma Canada Inc.	20250707
43a91066-1d85-4f67-9856-a11c1bb2b22b	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Bryant Ranch Prepack	20241120
45c9512b-9463-4684-bfdb-742644d77cc3	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Bryant Ranch Prepack	20240814
f5b30e5e-b067-e28c-b7c5-aa58f4c57f09	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment 0.1%, for topical use Initial U.S. Approval: 1987	Cosette Pharmaceuticals, Inc. \| Cosette Pharmaceuticals NC Laboratories, LLC	20231129
c3053a64-9044-496e-9005-12b4440d46e8	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Bryant Ranch Prepack	20231020
c5bd3e82-bce7-48e8-9818-01bedaa19356	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	REMEDYREPACK INC.	20230929
a6055a9c-e19c-48ad-a743-c0a7f7366cdd	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Bryant Ranch Prepack	20230718
9fe65193-b4d8-480b-89b3-178cd1b20713	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	A-S Medication Solutions	20230215
d986282f-da3c-43b6-a3f6-40886d4a1915	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT . MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Padagis Israel Pharmaceuticals Ltd	20230101
a912221d-aa22-428e-ab4d-f2ddaa78f458	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment, 0.1% for topical use Initial U.S. Approval: 1987	Cosette Pharmaceuticals, Inc.	20220430
aa905762-80be-45be-89d5-b32564e82f92	These highlights do not include all the information needed to use ELOCON Ointment safely and effectively. See full prescribing information for ELOCON Ointment. ELOCON ® (mometasone furoate) Ointment, 0.1% for topical use Initial U.S. Approval: 1987	Merck Sharp & Dohme Corp.	20210901
209c15dd-72b2-4f00-a2f0-011219f7eaea	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE Ointment, 0.1% for topical use Initial U.S. Approval: 1987	Glenmark Pharmaceuticals Inc., USA \| Glenmark Pharmaceuticals Limited	20210223
05ae3b84-d187-4bf9-b656-61c88874ecbd	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	REMEDYREPACK INC.	20200225
c08fcb0d-7fff-4d90-aeb8-e912b930bf3d	These highlights do not include all the information needed to use MOMETASONE FUROATE OINTMENT safely and effectively. See full prescribing information for MOMETASONE FUROATE OINTMENT. MOMETASONE FUROATE ointment, for topical use Initial U.S. Approval: 1987	Proficient Rx LP	20200201
f6897296-8235-4026-9f76-f7a31cde5936	These highlights do not include all the information needed to use Mometasone Furoate, USP Ointment 0.1% safely and effectively. See full prescribing information for Mometasone Furoate, USP Ointment 0.1%. Mometasone Furoate, USP Ointment 0.1% for topical use Initial U.S. Approval: 1987	REMEDYREPACK INC.	20170515
1d34727e-821f-4ad9-a672-582fd7e4499b		National Council for Prescription Drug Programs	20130213
59075f02-be01-4d0c-9f23-ebaab81744c7		National Council for Prescription Drug Programs	20130213
ca89394c-8c69-4b73-96cd-2fe90dbef7db		National Council for Prescription Drug Programs	20120724
06b77644-d7ac-4eaf-94a2-01b63716412b		National Council for Prescription Drug Programs	20120724
0ccbbc03-c581-47a8-856c-15869c1dc82a		National Council for Prescription Drug Programs	20120724
0f5fc3bc-fae9-49a1-b545-7feb3065df6c		National Council for Prescription Drug Programs	20120724
3075b4b3-9d64-4560-b0df-ee1c4c7163b2		National Council for Prescription Drug Programs	20120724
335bd34e-3234-4f6f-8ca1-7ccbaeeaf60c		National Council for Prescription Drug Programs	20120724
4052ed7e-4eb3-4d02-b223-57958ee4ade1		National Council for Prescription Drug Programs	20120724
cd05156a-4080-434e-9fb1-ea73ca6fba07		National Council for Prescription Drug Programs	20120724
a3e63a1f-d91f-4bda-81dc-fea22b3e8d10		National Council for Prescription Drug Programs	20120724
51674a82-c64b-4495-b89a-faef3c30ee87		National Council for Prescription Drug Programs	20120724
64b09fa0-6aaf-45bb-abe2-12ad92766c3e		National Council for Prescription Drug Programs	20120724
6534eaac-fd1e-4b6f-87c3-eac16f38225c		National Council for Prescription Drug Programs	20120724
8532e6a5-0934-46db-8d0a-301bf007b649		National Council for Prescription Drug Programs	20120724
b10b21a9-428a-4b3b-9dcf-ea92501b114e		National Council for Prescription Drug Programs	20120724
ab2fa958-2e07-4801-a696-9c34105e4401		National Council for Prescription Drug Programs	20120724

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	R01AD	Corticosteroids	ATC1-4		mometasone
ATC	D07AC	Corticosteroids, potent (group III)	ATC1-4		mometasone
ATC	D07XC	Corticosteroids, potent, other combinations	ATC1-4		mometasone
ATC	R03BA	Glucocorticoids	ATC1-4		mometasone
FDASPL	N0000175576	Corticosteroid	EPC	has_epc	mometasone
FDASPL	N0000175450	Corticosteroid Hormone Receptor Agonists	MOA	has_moa	mometasone
MEDRT	D000068656	Mometasone Furoate	CHEM	has_ingredient	mometasone
MEDRT	D000068656	Mometasone Furoate	CHEM	has_ingredient	mometasone furoate
MEDRT	D003881	Dermatomycoses	DISEASE	ci_with	mometasone
MEDRT	D003881	Dermatomycoses	DISEASE	ci_with	mometasone furoate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	mometasone furoate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	mometasone
MEDRT	D005148	Facial Dermatoses	DISEASE	may_treat	mometasone furoate
MEDRT	D005148	Facial Dermatoses	DISEASE	may_treat	mometasone
MEDRT	D005533	Foot Dermatoses	DISEASE	may_treat	mometasone
MEDRT	D005533	Foot Dermatoses	DISEASE	may_treat	mometasone furoate
MEDRT	D006229	Hand Dermatoses	DISEASE	may_treat	mometasone
MEDRT	D006229	Hand Dermatoses	DISEASE	may_treat	mometasone furoate
MEDRT	D006561	Herpes Simplex	DISEASE	ci_with	mometasone furoate
MEDRT	D006561	Herpes Simplex	DISEASE	ci_with	mometasone
MEDRT	D006562	Herpes Zoster	DISEASE	ci_with	mometasone furoate
MEDRT	D006562	Herpes Zoster	DISEASE	ci_with	mometasone
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	mometasone furoate
MEDRT	D007249	Inflammation	DISEASE	may_treat	mometasone furoate
MEDRT	D007249	Inflammation	DISEASE	may_treat	mometasone
MEDRT	D007868	Leg Dermatoses	DISEASE	may_treat	mometasone furoate
MEDRT	D007868	Leg Dermatoses	DISEASE	may_treat	mometasone
MEDRT	D011537	Pruritus	DISEASE	may_treat	mometasone furoate
MEDRT	D011537	Pruritus	DISEASE	may_treat	mometasone
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	mometasone
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	mometasone furoate
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	mometasone
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	mometasone furoate
MEDRT	D014382	Tuberculosis, Cutaneous	DISEASE	ci_with	mometasone
MEDRT	D014382	Tuberculosis, Cutaneous	DISEASE	ci_with	mometasone furoate
MEDRT	N0000000159	Glucocorticoid Receptor Agonists	MOA	has_moa	mometasone
MEDRT	N0000000159	Glucocorticoid Receptor Agonists	MOA	has_moa	mometasone furoate
MEDRT	N0000000134	Lipoxygenase Inhibitors	MOA	has_moa	mometasone
MEDRT	N0000000134	Lipoxygenase Inhibitors	MOA	has_moa	mometasone furoate
MEDRT	N0000008681	Decreased Leukotriene Activity	PE	has_pe	mometasone
MEDRT	N0000008681	Decreased Leukotriene Activity	PE	has_pe	mometasone furoate
MEDRT	N0000008834	Decreased Prostaglandin Activity	PE	has_pe	mometasone
MEDRT	N0000008834	Decreased Prostaglandin Activity	PE	has_pe	mometasone furoate
MEDRT	N0000008841	Decreased Protein Synthesis	PE	has_pe	mometasone
MEDRT	N0000008841	Decreased Protein Synthesis	PE	has_pe	mometasone furoate
MEDRT	N0000009004	Decreased Thromboxane Activity	PE	has_pe	mometasone
MEDRT	N0000009004	Decreased Thromboxane Activity	PE	has_pe	mometasone furoate
MEDRT	N0000009908	Vasoconstriction	PE	has_pe	mometasone
MEDRT	N0000009908	Vasoconstriction	PE	has_pe	mometasone furoate

Group, Type, Concept table
Group	Type	Concept	Source
DF	DF	Topical Ointment	rxnav_allrelated
DFG	DFG	Topical Product	rxnav_allrelated
IN	IN	mometasone	rxnav_allrelated
PIN	PIN	mometasone furoate	rxnav_allrelated
SCD	SCD	mometasone furoate 0.001 MG/MG Topical Ointment	rxnav_allrelated
SCDC	SCDC	mometasone furoate 0.001 MG/MG	rxnav_allrelated
SCDF	SCDF	mometasone Topical Ointment	rxnav_allrelated
SCDFP	SCDFP	mometasone furoate Topical Ointment	rxnav_allrelated
SCDG	SCDG	mometasone Topical Product	rxnav_allrelated
SCDGP	SCDGP	mometasone furoate Topical Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	0.001 MG/MG
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	ANDA	ANDA076067
CODES	ANDA	ANDA076481
CODES	ANDA	ANDA077401
CODES	ANDA	ANDA207899
CODES	SNOMEDCT	332050000
CODES	VUID	4008538
NAMES	Prescribable Synonym	mometasone furoate 0.1 % Topical Ointment
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	US Edition of SNOMED_CT
SOURCES	Source	Veterans Health Administration National Drug File